COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

COSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Recruitment Information:

Seeking volunteers with following diagnosis: PD Study Type: Observational
Eligible Ages: 18 - 99 Status: Not yet recruiting
Time Since Diagnosis: Any may be eligible Study Focus:

Study Purpose:

The purpose of this study is to evaluate treatment of advanced Parkinson's Disease (PD) patients on levodopa-carbidopa intestinal gel (LCIG) monotherapy in a routine clinical setting.

Find a Site Location and Contact the Trial Team

More Details

Patients with advanced Parkinson's Disease who have been prescribed LCIG for at least 12 months will be entered into the study cohort. Clinical data will be collected by retrospective review of the patient's medical records as well as a single study visit for current data. Treatment of the patients and follow up will be according to the physician's judgment, regional regulations and the product monograph.

Phase: N/A Lead Sponsor: AbbVie
Trial ID: 005130 Sponsor Type: Industry
Primary Country: Canada Additional Collaborators or Sponsors:
Estimated Enrollment: 400 Study Start Date: December 2017
Estimated Study Completion Date: December 2018 Source: ClinicalTrials.gov
Study Website:

More Inclusion & Exclusion Criteria

Share This Trial


Fox Trial Finder strives to make all trial postings as accurate and complete as possible. If you believe any of the information on this page is not accurate, click here to contact us. Thank you for your support.

Choose your location

Please select a Trial Location.
x

Confirmation

You have favorited this trial!

This trial will be listed in the "Favorites" category of your dashboard.
x

Confirmation

You are not interested.

This trial will be listed in the "Not Interested" category on your dashboard. You can click "Interested" if you change your mind.
x

Message to Trial Coordinator

Your message was sent.

Your message was sent to the trial team at the location you selected. Check your dashboard for a response.

Login to My Trial Finder

Please enter your email address and password to access your My Fox Trial Finder dashboard.

*indicates required field.
x

Contact Fox Trial Finder

What best describes you?





*indicates required field.
x